"Drug Utilization Review" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Formal programs for assessing drug prescription against some standard. Drug utilization review may consider clinical appropriateness, cost effectiveness, and, in some cases, outcomes. Review is usually retrospective, but some analysis may be done before drugs are dispensed (as in computer systems which advise physicians when prescriptions are entered). Drug utilization review is mandated for Medicaid programs beginning in 1993.
| Descriptor ID |
D017723
|
| MeSH Number(s) |
N04.452.706.477.400 N04.761.879.300 N05.700.900.300
|
| Concept/Terms |
Drug Utilization Review- Drug Utilization Review
- Evaluation, Drug Utilization
- Drug-Use Review
- Drug Use Review
- Drug-Use Reviews
- Reviews, Drug-Use
- Review, Drug Utilization
- Drug Utilization Reviews
- Reviews, Drug Utilization
- Utilization Reviews, Drug
- Utilization Review, Drug
- Drug Utilization Evaluation
- Drug Utilization Evaluations
- Evaluations, Drug Utilization
- Utilization Evaluation, Drug
- Utilization Evaluations, Drug
- Review, Drug-Use
- Review, Drug Use
|
Below are MeSH descriptors whose meaning is more general than "Drug Utilization Review".
Below are MeSH descriptors whose meaning is more specific than "Drug Utilization Review".
This graph shows the total number of publications written about "Drug Utilization Review" by people in this website by year, and whether "Drug Utilization Review" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1996 | 2 | 0 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2006 | 2 | 0 | 2 |
| 2007 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Utilization Review" by people in Profiles.
-
Change in Antimicrobial Use During COVID-19 Pandemic in South Carolina Hospitals: A Multicenter Observational Cohort Study. Int J Antimicrob Agents. 2021 Dec; 58(6):106453.
-
Variability in the community consumption of antibiotics: a problem in Europe, Spain and Asturias. Infez Med. 2019 Jun 01; 27(2):134-140.
-
Type 2 Diabetes Medication Review. Am J Med Sci. 2016 Apr; 351(4):342-55.
-
Safety and cost-effectiveness of a clinical protocol implemented to standardize the use of Crotalidae polyvalent immune Fab antivenom at an academic medical center. Pharmacotherapy. 2012 May; 32(5):433-40.
-
Reassessments of ESAs for cancer treatment in the US and Europe. Oncology (Williston Park). 2010 Mar; 24(3):260-8.
-
Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate. Clin Cancer Res. 2009 Jun 01; 15(11):3850-5.
-
Systematic review of piperacillin-induced neutropenia. Drug Saf. 2007; 30(4):295-306.
-
Antihypertensive prescribing practices: impact of the antihypertensive and lipid-lowering treatment to prevent heart attack trial. J Clin Hypertens (Greenwich). 2006 Dec; 8(12):860-4.
-
Effects of direct-to-consumer advertising of hydroxymethylglutaryl coenzyme a reductase inhibitors on attainment of LDL-C goals. Clin Ther. 2006 Dec; 28(12):2105-18; discussion 2104.
-
Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med. 2004 Mar 15; 116(6):394-401.